Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
WT1
|
ENSG00000184937.16 | WT1 |
MTF1
|
ENSG00000188786.10 | MTF1 |
ZBTB7B
|
ENSG00000160685.13 | ZBTB7B |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
WT1 | hg38_v1_chr11_-_32435529_32435549 | 0.32 | 8.2e-02 | Click! |
MTF1 | hg38_v1_chr1_-_37859583_37859609 | -0.17 | 3.7e-01 | Click! |
ZBTB7B | hg38_v1_chr1_+_155002630_155002689 | -0.16 | 4.1e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_708903 | 2.75 |
ENST00000338448.10
ENST00000264560.11 |
PALM
|
paralemmin |
chr3_+_13549117 | 1.72 |
ENST00000404922.8
|
FBLN2
|
fibulin 2 |
chr19_-_14979676 | 1.55 |
ENST00000598504.5
ENST00000597262.1 |
SLC1A6
|
solute carrier family 1 member 6 |
chr16_-_88941198 | 1.52 |
ENST00000327483.9
ENST00000564416.1 |
CBFA2T3
|
CBFA2/RUNX1 partner transcriptional co-repressor 3 |
chr11_+_369461 | 1.49 |
ENST00000329962.11
|
B4GALNT4
|
beta-1,4-N-acetyl-galactosaminyltransferase 4 |
chrX_+_153072454 | 1.42 |
ENST00000421798.5
|
PNMA6A
|
PNMA family member 6A |
chr3_+_13549136 | 1.38 |
ENST00000295760.11
|
FBLN2
|
fibulin 2 |
chr16_+_1153098 | 1.33 |
ENST00000348261.11
|
CACNA1H
|
calcium voltage-gated channel subunit alpha1 H |
chr22_+_23070496 | 1.30 |
ENST00000615612.2
|
GNAZ
|
G protein subunit alpha z |
chr16_-_705726 | 1.28 |
ENST00000397621.6
ENST00000324361.9 |
FBXL16
|
F-box and leucine rich repeat protein 16 |
chr19_+_50203607 | 1.26 |
ENST00000642316.2
ENST00000425460.6 ENST00000440075.6 ENST00000376970.6 ENST00000599920.5 |
MYH14
|
myosin heavy chain 14 |
chr15_-_93089192 | 1.24 |
ENST00000329082.11
|
RGMA
|
repulsive guidance molecule BMP co-receptor a |
chr21_+_45643711 | 1.20 |
ENST00000681687.1
|
PCBP3
|
poly(rC) binding protein 3 |
chr10_+_133160194 | 1.20 |
ENST00000478074.6
ENST00000684248.1 ENST00000304613.8 |
KNDC1
|
kinase non-catalytic C-lobe domain containing 1 |
chr21_+_45643694 | 1.16 |
ENST00000400314.5
|
PCBP3
|
poly(rC) binding protein 3 |
chr9_-_21994345 | 1.14 |
ENST00000579755.2
ENST00000530628.2 |
CDKN2A
|
cyclin dependent kinase inhibitor 2A |
chr5_+_168529299 | 1.13 |
ENST00000338333.5
|
FBLL1
|
fibrillarin like 1 |
chr16_-_981259 | 1.12 |
ENST00000563837.1
ENST00000563863.5 ENST00000565069.5 ENST00000570014.5 |
CEROX1
LMF1
|
cytoplasmic endogenous regulator of oxidative phosphorylation 1 lipase maturation factor 1 |
chr8_-_139704091 | 1.09 |
ENST00000648164.1
|
KCNK9
|
potassium two pore domain channel subfamily K member 9 |
chr19_-_47419490 | 1.08 |
ENST00000331559.9
ENST00000558555.6 |
MEIS3
|
Meis homeobox 3 |
chr4_+_41360759 | 1.08 |
ENST00000508501.5
ENST00000512946.5 ENST00000313860.11 ENST00000512632.5 ENST00000512820.5 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr1_+_7784251 | 1.04 |
ENST00000377532.8
ENST00000377541.5 |
PER3
|
period circadian regulator 3 |
chr7_-_51316754 | 1.03 |
ENST00000632460.1
ENST00000441453.5 ENST00000648294.1 ENST00000265136.12 ENST00000395542.6 ENST00000395540.6 |
COBL
|
cordon-bleu WH2 repeat protein |
chr6_-_11044275 | 1.02 |
ENST00000354666.4
|
ELOVL2
|
ELOVL fatty acid elongase 2 |
chr3_-_125055987 | 1.01 |
ENST00000311127.9
|
HEG1
|
heart development protein with EGF like domains 1 |
chr19_-_18606779 | 1.01 |
ENST00000684169.1
ENST00000392386.8 |
CRLF1
|
cytokine receptor like factor 1 |
chr19_+_35030711 | 1.00 |
ENST00000595652.5
|
SCN1B
|
sodium voltage-gated channel beta subunit 1 |
chr3_-_50503597 | 0.97 |
ENST00000266039.7
ENST00000424201.7 |
CACNA2D2
|
calcium voltage-gated channel auxiliary subunit alpha2delta 2 |
chr2_+_30231524 | 0.95 |
ENST00000395323.9
ENST00000406087.5 ENST00000404397.5 |
LBH
|
LBH regulator of WNT signaling pathway |
chr3_+_87792697 | 0.95 |
ENST00000319595.7
|
HTR1F
|
5-hydroxytryptamine receptor 1F |
chr6_-_4079100 | 0.93 |
ENST00000492651.5
ENST00000498677.5 ENST00000274673.8 |
FAM217A
|
family with sequence similarity 217 member A |
chr12_-_124567464 | 0.92 |
ENST00000458234.5
|
NCOR2
|
nuclear receptor corepressor 2 |
chr21_+_42653734 | 0.91 |
ENST00000335512.8
ENST00000328862.10 ENST00000335440.10 ENST00000380328.6 ENST00000398225.7 ENST00000398227.7 ENST00000398229.7 ENST00000398232.7 ENST00000398234.7 ENST00000398236.7 ENST00000349112.7 ENST00000398224.3 |
PDE9A
|
phosphodiesterase 9A |
chr14_+_52552830 | 0.91 |
ENST00000321662.11
|
GPR137C
|
G protein-coupled receptor 137C |
chr4_-_1683991 | 0.91 |
ENST00000472884.6
ENST00000489363.5 ENST00000308132.10 |
FAM53A
|
family with sequence similarity 53 member A |
chr19_+_34481736 | 0.91 |
ENST00000590071.7
|
WTIP
|
WT1 interacting protein |
chr8_-_141308280 | 0.91 |
ENST00000517878.6
|
SLC45A4
|
solute carrier family 45 member 4 |
chr1_+_7784411 | 0.90 |
ENST00000613533.4
ENST00000614998.4 |
PER3
|
period circadian regulator 3 |
chr10_+_115093404 | 0.90 |
ENST00000527407.5
|
ATRNL1
|
attractin like 1 |
chr17_+_57256727 | 0.89 |
ENST00000675656.1
|
MSI2
|
musashi RNA binding protein 2 |
chr22_-_19150292 | 0.88 |
ENST00000086933.3
|
GSC2
|
goosecoid homeobox 2 |
chr4_-_16083714 | 0.88 |
ENST00000508167.5
|
PROM1
|
prominin 1 |
chr16_+_590200 | 0.87 |
ENST00000563109.1
|
RAB40C
|
RAB40C, member RAS oncogene family |
chr3_+_49554436 | 0.87 |
ENST00000296452.5
|
BSN
|
bassoon presynaptic cytomatrix protein |
chr2_+_120346130 | 0.87 |
ENST00000295228.4
|
INHBB
|
inhibin subunit beta B |
chr14_-_100159595 | 0.87 |
ENST00000553834.1
ENST00000305631.7 |
DEGS2
|
delta 4-desaturase, sphingolipid 2 |
chr19_-_50719761 | 0.86 |
ENST00000293441.6
|
SHANK1
|
SH3 and multiple ankyrin repeat domains 1 |
chr16_+_1153202 | 0.85 |
ENST00000358590.8
ENST00000638323.1 |
CACNA1H
|
calcium voltage-gated channel subunit alpha1 H |
chr19_-_49119092 | 0.85 |
ENST00000408991.4
|
C19orf73
|
chromosome 19 open reading frame 73 |
chr19_+_8209300 | 0.85 |
ENST00000558268.5
ENST00000558331.5 |
CERS4
|
ceramide synthase 4 |
chr15_-_78811415 | 0.85 |
ENST00000388820.5
|
ADAMTS7
|
ADAM metallopeptidase with thrombospondin type 1 motif 7 |
chr19_-_5567984 | 0.84 |
ENST00000448587.5
|
TINCR
|
TINCR ubiquitin domain containing |
chr1_-_223364059 | 0.84 |
ENST00000343846.7
ENST00000484758.6 ENST00000344029.6 ENST00000366878.9 ENST00000494793.6 ENST00000681285.1 ENST00000680429.1 ENST00000681669.1 ENST00000681305.1 |
SUSD4
|
sushi domain containing 4 |
chr5_+_1008794 | 0.83 |
ENST00000296849.10
|
NKD2
|
NKD inhibitor of WNT signaling pathway 2 |
chr4_-_16083695 | 0.83 |
ENST00000510224.5
|
PROM1
|
prominin 1 |
chr7_-_149497664 | 0.83 |
ENST00000461958.2
|
ZNF746
|
zinc finger protein 746 |
chr20_-_63499074 | 0.83 |
ENST00000217182.6
ENST00000642899.1 |
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr14_+_105526568 | 0.82 |
ENST00000392519.7
|
TMEM121
|
transmembrane protein 121 |
chr19_-_461007 | 0.81 |
ENST00000264554.11
|
SHC2
|
SHC adaptor protein 2 |
chr8_-_139702998 | 0.80 |
ENST00000303015.2
|
KCNK9
|
potassium two pore domain channel subfamily K member 9 |
chr1_+_205569005 | 0.80 |
ENST00000367147.9
ENST00000489709.5 |
MFSD4A
|
major facilitator superfamily domain containing 4A |
chr4_-_8871817 | 0.80 |
ENST00000400677.5
|
HMX1
|
H6 family homeobox 1 |
chr4_-_2262082 | 0.79 |
ENST00000337190.7
|
MXD4
|
MAX dimerization protein 4 |
chr22_-_38455199 | 0.79 |
ENST00000303592.3
|
KCNJ4
|
potassium inwardly rectifying channel subfamily J member 4 |
chr1_+_2019379 | 0.79 |
ENST00000638771.1
ENST00000640949.1 ENST00000640030.1 |
GABRD
|
gamma-aminobutyric acid type A receptor subunit delta |
chr2_+_42048012 | 0.79 |
ENST00000294964.6
|
PKDCC
|
protein kinase domain containing, cytoplasmic |
chr2_+_6917404 | 0.79 |
ENST00000320892.11
|
RNF144A
|
ring finger protein 144A |
chr18_-_5296139 | 0.78 |
ENST00000400143.7
|
ZBTB14
|
zinc finger and BTB domain containing 14 |
chr4_+_2059286 | 0.78 |
ENST00000423729.3
|
NAT8L
|
N-acetyltransferase 8 like |
chr15_-_26773022 | 0.78 |
ENST00000311550.10
ENST00000622697.4 |
GABRB3
|
gamma-aminobutyric acid type A receptor subunit beta3 |
chr14_-_52791462 | 0.78 |
ENST00000650397.1
ENST00000554230.5 |
GNPNAT1
|
glucosamine-phosphate N-acetyltransferase 1 |
chr12_-_54588636 | 0.78 |
ENST00000257905.13
|
PPP1R1A
|
protein phosphatase 1 regulatory inhibitor subunit 1A |
chr19_+_8209320 | 0.77 |
ENST00000561053.5
ENST00000559450.5 ENST00000251363.10 ENST00000559336.5 |
CERS4
|
ceramide synthase 4 |
chr9_-_33167296 | 0.77 |
ENST00000379731.5
ENST00000535206.5 |
B4GALT1
|
beta-1,4-galactosyltransferase 1 |
chr7_+_139778229 | 0.77 |
ENST00000425687.5
ENST00000650822.1 ENST00000416849.6 ENST00000438104.6 ENST00000336425.10 |
TBXAS1
|
thromboxane A synthase 1 |
chr16_+_56191476 | 0.77 |
ENST00000262493.12
|
GNAO1
|
G protein subunit alpha o1 |
chr16_-_55833085 | 0.77 |
ENST00000360526.8
|
CES1
|
carboxylesterase 1 |
chr20_-_63831214 | 0.77 |
ENST00000302995.2
ENST00000245663.9 |
ZBTB46
|
zinc finger and BTB domain containing 46 |
chr19_-_47419109 | 0.76 |
ENST00000559524.5
ENST00000557833.1 ENST00000561293.5 ENST00000441740.6 |
MEIS3
|
Meis homeobox 3 |
chr10_-_13001705 | 0.76 |
ENST00000378825.5
|
CCDC3
|
coiled-coil domain containing 3 |
chr14_+_96039328 | 0.76 |
ENST00000553764.1
ENST00000555004.3 ENST00000556728.1 ENST00000553782.1 |
C14orf132
|
chromosome 14 open reading frame 132 |
chr22_-_30574572 | 0.75 |
ENST00000402369.5
|
GAL3ST1
|
galactose-3-O-sulfotransferase 1 |
chr6_-_29628038 | 0.75 |
ENST00000355973.7
ENST00000377012.8 |
GABBR1
|
gamma-aminobutyric acid type B receptor subunit 1 |
chrX_-_129654946 | 0.75 |
ENST00000429967.3
|
APLN
|
apelin |
chr1_+_212608628 | 0.74 |
ENST00000613954.4
ENST00000341491.9 ENST00000366985.5 |
ATF3
|
activating transcription factor 3 |
chr17_+_79778135 | 0.74 |
ENST00000310942.9
ENST00000269399.5 |
CBX2
|
chromobox 2 |
chr20_+_13995369 | 0.73 |
ENST00000217246.8
ENST00000684519.1 ENST00000642719.1 |
MACROD2
|
mono-ADP ribosylhydrolase 2 |
chr17_-_43833137 | 0.73 |
ENST00000398389.9
|
MPP3
|
membrane palmitoylated protein 3 |
chr5_+_92106 | 0.73 |
ENST00000637938.1
|
PLEKHG4B
|
pleckstrin homology and RhoGEF domain containing G4B |
chr22_-_38398480 | 0.73 |
ENST00000400206.7
|
TPTEP2-CSNK1E
|
TPTEP2-CSNK1E readthrough |
chr7_+_44104326 | 0.73 |
ENST00000223357.8
|
AEBP1
|
AE binding protein 1 |
chr5_-_180649613 | 0.73 |
ENST00000393347.7
ENST00000619105.4 |
FLT4
|
fms related receptor tyrosine kinase 4 |
chr3_-_115147237 | 0.72 |
ENST00000357258.8
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr14_-_95319863 | 0.72 |
ENST00000298912.9
|
CLMN
|
calmin |
chr19_+_8364146 | 0.72 |
ENST00000301455.7
ENST00000393962.6 |
ANGPTL4
|
angiopoietin like 4 |
chr22_+_41381923 | 0.72 |
ENST00000266304.9
|
TEF
|
TEF transcription factor, PAR bZIP family member |
chr17_-_76240478 | 0.72 |
ENST00000269391.11
|
RNF157
|
ring finger protein 157 |
chr9_+_136665745 | 0.72 |
ENST00000371698.3
|
EGFL7
|
EGF like domain multiple 7 |
chr21_+_42653585 | 0.71 |
ENST00000291539.11
|
PDE9A
|
phosphodiesterase 9A |
chr7_-_158587710 | 0.71 |
ENST00000389416.8
|
PTPRN2
|
protein tyrosine phosphatase receptor type N2 |
chr17_-_3893040 | 0.70 |
ENST00000158166.5
ENST00000348335.7 |
CAMKK1
|
calcium/calmodulin dependent protein kinase kinase 1 |
chr17_+_38705482 | 0.70 |
ENST00000620609.4
|
MLLT6
|
MLLT6, PHD finger containing |
chr11_-_93543382 | 0.70 |
ENST00000298966.7
|
SMCO4
|
single-pass membrane protein with coiled-coil domains 4 |
chr16_-_89201635 | 0.70 |
ENST00000562855.7
|
SLC22A31
|
solute carrier family 22 member 31 |
chr2_+_5692357 | 0.70 |
ENST00000322002.5
|
SOX11
|
SRY-box transcription factor 11 |
chrX_+_153179276 | 0.69 |
ENST00000356661.7
|
MAGEA1
|
MAGE family member A1 |
chr10_+_11742361 | 0.69 |
ENST00000379215.9
ENST00000420401.5 |
ECHDC3
|
enoyl-CoA hydratase domain containing 3 |
chr1_+_220690354 | 0.69 |
ENST00000294889.6
|
C1orf115
|
chromosome 1 open reading frame 115 |
chr17_-_56833889 | 0.69 |
ENST00000397861.7
|
C17orf67
|
chromosome 17 open reading frame 67 |
chr7_+_66629023 | 0.69 |
ENST00000639879.1
ENST00000640851.1 |
KCTD7
|
potassium channel tetramerization domain containing 7 |
chr16_+_726936 | 0.69 |
ENST00000549114.5
ENST00000341413.8 ENST00000562187.1 ENST00000564537.5 ENST00000389703.8 |
HAGHL
|
hydroxyacylglutathione hydrolase like |
chr19_+_51311638 | 0.69 |
ENST00000270642.9
|
IGLON5
|
IgLON family member 5 |
chr7_-_139777774 | 0.68 |
ENST00000428878.6
|
HIPK2
|
homeodomain interacting protein kinase 2 |
chr5_+_10564064 | 0.68 |
ENST00000296657.7
|
ANKRD33B
|
ankyrin repeat domain 33B |
chr3_-_115147277 | 0.68 |
ENST00000675478.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr4_+_146638890 | 0.68 |
ENST00000281321.3
|
POU4F2
|
POU class 4 homeobox 2 |
chr19_-_5567831 | 0.68 |
ENST00000587632.1
ENST00000646160.1 |
TINCR
|
TINCR ubiquitin domain containing |
chr16_-_55833186 | 0.68 |
ENST00000361503.8
ENST00000422046.6 |
CES1
|
carboxylesterase 1 |
chr19_+_49513154 | 0.67 |
ENST00000426395.7
ENST00000600273.5 ENST00000599988.5 |
FCGRT
|
Fc fragment of IgG receptor and transporter |
chr10_+_120457197 | 0.67 |
ENST00000398250.6
|
PLPP4
|
phospholipid phosphatase 4 |
chr17_-_78925376 | 0.67 |
ENST00000262768.11
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr16_-_2340703 | 0.67 |
ENST00000301732.10
ENST00000382381.7 |
ABCA3
|
ATP binding cassette subfamily A member 3 |
chr1_-_201115372 | 0.67 |
ENST00000458416.2
|
ASCL5
|
achaete-scute family bHLH transcription factor 5 |
chr11_-_65919026 | 0.66 |
ENST00000438576.3
ENST00000449692.3 |
C11orf68
|
chromosome 11 open reading frame 68 |
chr9_-_13279407 | 0.66 |
ENST00000546205.5
|
MPDZ
|
multiple PDZ domain crumbs cell polarity complex component |
chr7_+_73667824 | 0.66 |
ENST00000324941.5
ENST00000451519.1 |
VPS37D
|
VPS37D subunit of ESCRT-I |
chr14_+_52553273 | 0.66 |
ENST00000542169.6
ENST00000555622.1 |
GPR137C
|
G protein-coupled receptor 137C |
chr22_-_17121311 | 0.65 |
ENST00000331437.4
ENST00000399875.1 |
TMEM121B
|
transmembrane protein 121B |
chr22_+_19714450 | 0.65 |
ENST00000455784.7
ENST00000406395.5 |
SEPTIN5
|
septin 5 |
chr1_+_2019324 | 0.65 |
ENST00000638411.1
ENST00000378585.7 ENST00000640067.1 |
GABRD
|
gamma-aminobutyric acid type A receptor subunit delta |
chr17_-_82698637 | 0.65 |
ENST00000538809.6
ENST00000269347.10 ENST00000571995.6 |
RAB40B
|
RAB40B, member RAS oncogene family |
chr9_-_137054016 | 0.64 |
ENST00000312665.7
ENST00000355097.7 |
ENTPD2
|
ectonucleoside triphosphate diphosphohydrolase 2 |
chr7_-_158587773 | 0.64 |
ENST00000389413.7
ENST00000409483.5 ENST00000389418.9 |
PTPRN2
|
protein tyrosine phosphatase receptor type N2 |
chr14_+_99684283 | 0.64 |
ENST00000261835.8
|
CYP46A1
|
cytochrome P450 family 46 subfamily A member 1 |
chr19_-_8149586 | 0.64 |
ENST00000600128.6
|
FBN3
|
fibrillin 3 |
chr9_+_137877773 | 0.64 |
ENST00000371372.6
ENST00000277551.6 ENST00000277549.9 ENST00000371363.5 ENST00000371355.8 ENST00000371357.5 |
CACNA1B
|
calcium voltage-gated channel subunit alpha1 B |
chr1_-_241357085 | 0.64 |
ENST00000366564.5
|
RGS7
|
regulator of G protein signaling 7 |
chr2_+_231037500 | 0.64 |
ENST00000373640.5
|
C2orf72
|
chromosome 2 open reading frame 72 |
chr16_+_58463663 | 0.64 |
ENST00000258187.9
|
NDRG4
|
NDRG family member 4 |
chr16_+_1309714 | 0.63 |
ENST00000566587.5
|
UBE2I
|
ubiquitin conjugating enzyme E2 I |
chr20_+_2692736 | 0.63 |
ENST00000380648.9
ENST00000497450.5 |
EBF4
|
EBF family member 4 |
chr1_+_109668022 | 0.63 |
ENST00000442650.5
ENST00000369831.6 ENST00000369827.7 ENST00000460717.7 ENST00000241337.9 ENST00000467579.7 ENST00000414179.6 ENST00000369829.2 |
GSTM2
|
glutathione S-transferase mu 2 |
chr7_+_66629078 | 0.63 |
ENST00000449064.6
ENST00000638540.1 ENST00000640234.1 |
KCTD7
|
potassium channel tetramerization domain containing 7 |
chr14_-_103521342 | 0.63 |
ENST00000553610.5
|
CKB
|
creatine kinase B |
chr22_-_30574654 | 0.63 |
ENST00000406361.6
|
GAL3ST1
|
galactose-3-O-sulfotransferase 1 |
chr17_+_4807119 | 0.63 |
ENST00000263088.11
ENST00000572940.5 |
PLD2
|
phospholipase D2 |
chr19_+_12995554 | 0.62 |
ENST00000397661.6
|
NFIX
|
nuclear factor I X |
chr16_-_1872107 | 0.62 |
ENST00000496541.6
ENST00000325962.9 ENST00000397344.7 |
MEIOB
|
meiosis specific with OB-fold |
chr12_-_54588516 | 0.62 |
ENST00000547431.5
|
PPP1R1A
|
protein phosphatase 1 regulatory inhibitor subunit 1A |
chr22_+_43412008 | 0.62 |
ENST00000334209.9
ENST00000443721.2 |
MPPED1
|
metallophosphoesterase domain containing 1 |
chr7_-_159144852 | 0.62 |
ENST00000421760.2
ENST00000402066.5 ENST00000262178.7 |
VIPR2
|
vasoactive intestinal peptide receptor 2 |
chr9_+_83623102 | 0.61 |
ENST00000376419.5
ENST00000530832.5 ENST00000405990.3 ENST00000376417.8 |
IDNK
|
IDNK gluconokinase |
chr14_-_105168753 | 0.61 |
ENST00000331782.8
ENST00000347004.2 |
JAG2
|
jagged canonical Notch ligand 2 |
chr15_-_93073111 | 0.61 |
ENST00000557420.1
ENST00000542321.6 |
RGMA
|
repulsive guidance molecule BMP co-receptor a |
chr16_+_29806078 | 0.61 |
ENST00000545521.5
|
MAZ
|
MYC associated zinc finger protein |
chr1_+_228735431 | 0.61 |
ENST00000366691.4
|
RHOU
|
ras homolog family member U |
chr14_+_103334339 | 0.61 |
ENST00000558316.5
ENST00000558265.5 |
EIF5
|
eukaryotic translation initiation factor 5 |
chr3_+_23945271 | 0.61 |
ENST00000312521.9
|
NR1D2
|
nuclear receptor subfamily 1 group D member 2 |
chr8_+_27633863 | 0.60 |
ENST00000337221.8
|
SCARA3
|
scavenger receptor class A member 3 |
chr2_-_10080411 | 0.60 |
ENST00000381813.4
|
CYS1
|
cystin 1 |
chr19_+_1285859 | 0.60 |
ENST00000215368.4
|
EFNA2
|
ephrin A2 |
chr16_+_2026834 | 0.60 |
ENST00000424542.7
ENST00000432365.6 |
SLC9A3R2
|
SLC9A3 regulator 2 |
chr11_+_61508742 | 0.60 |
ENST00000378075.4
|
LRRC10B
|
leucine rich repeat containing 10B |
chr9_+_136712531 | 0.60 |
ENST00000371692.9
|
DIPK1B
|
divergent protein kinase domain 1B |
chr2_+_8682046 | 0.60 |
ENST00000331129.3
ENST00000396290.2 |
ID2
|
inhibitor of DNA binding 2 |
chr8_+_17497108 | 0.60 |
ENST00000470360.5
|
SLC7A2
|
solute carrier family 7 member 2 |
chr17_+_77140898 | 0.60 |
ENST00000585618.5
|
SEC14L1
|
SEC14 like lipid binding 1 |
chr7_+_66628864 | 0.60 |
ENST00000639828.2
ENST00000275532.8 ENST00000640385.1 |
KCTD7
|
potassium channel tetramerization domain containing 7 |
chr19_+_14433284 | 0.60 |
ENST00000242783.11
|
PKN1
|
protein kinase N1 |
chr7_-_139777986 | 0.59 |
ENST00000406875.8
|
HIPK2
|
homeodomain interacting protein kinase 2 |
chr18_+_62523385 | 0.59 |
ENST00000588676.1
|
ZCCHC2
|
zinc finger CCHC-type containing 2 |
chr7_-_712437 | 0.59 |
ENST00000360274.8
|
PRKAR1B
|
protein kinase cAMP-dependent type I regulatory subunit beta |
chr17_-_76240289 | 0.58 |
ENST00000647930.1
ENST00000592271.1 ENST00000319945.10 |
RNF157
|
ring finger protein 157 |
chr17_-_50129792 | 0.58 |
ENST00000503131.1
|
SAMD14
|
sterile alpha motif domain containing 14 |
chr1_-_202807988 | 0.58 |
ENST00000648738.1
ENST00000648354.1 |
KDM5B
|
lysine demethylase 5B |
chr16_-_66925526 | 0.58 |
ENST00000299759.11
ENST00000420652.5 |
RRAD
|
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
chr3_-_45226268 | 0.58 |
ENST00000503771.2
|
TMEM158
|
transmembrane protein 158 |
chr1_-_241357171 | 0.58 |
ENST00000440928.6
|
RGS7
|
regulator of G protein signaling 7 |
chr18_-_63319987 | 0.57 |
ENST00000398117.1
|
BCL2
|
BCL2 apoptosis regulator |
chr14_-_105181282 | 0.57 |
ENST00000392568.7
|
NUDT14
|
nudix hydrolase 14 |
chr7_-_152435786 | 0.57 |
ENST00000682283.1
ENST00000679882.1 ENST00000452749.2 ENST00000683616.1 ENST00000262189.11 ENST00000683490.1 ENST00000681082.1 ENST00000684550.1 |
KMT2C
|
lysine methyltransferase 2C |
chr17_+_44656429 | 0.57 |
ENST00000409122.7
|
MEIOC
|
meiosis specific with coiled-coil domain |
chr14_+_104724221 | 0.57 |
ENST00000330877.7
|
ADSS1
|
adenylosuccinate synthase 1 |
chr1_-_212699817 | 0.57 |
ENST00000243440.2
|
BATF3
|
basic leucine zipper ATF-like transcription factor 3 |
chr14_+_69484722 | 0.57 |
ENST00000322564.9
|
PLEKHD1
|
pleckstrin homology and coiled-coil domain containing D1 |
chr8_+_17497078 | 0.57 |
ENST00000494857.6
ENST00000522656.5 |
SLC7A2
|
solute carrier family 7 member 2 |
chr15_-_93073706 | 0.57 |
ENST00000425933.6
|
RGMA
|
repulsive guidance molecule BMP co-receptor a |
chr20_-_63472505 | 0.57 |
ENST00000360480.7
ENST00000344462.8 ENST00000625514.2 ENST00000629241.2 ENST00000629676.2 ENST00000370224.5 ENST00000359125.7 ENST00000344425.8 ENST00000626839.2 |
KCNQ2
|
potassium voltage-gated channel subfamily Q member 2 |
chr12_+_70366277 | 0.57 |
ENST00000258111.5
|
KCNMB4
|
potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
chr10_+_45374204 | 0.56 |
ENST00000374391.7
|
ALOX5
|
arachidonate 5-lipoxygenase |
chr22_-_31346143 | 0.56 |
ENST00000405309.7
ENST00000351933.8 |
PATZ1
|
POZ/BTB and AT hook containing zinc finger 1 |
chr8_+_55102012 | 0.56 |
ENST00000327381.7
|
XKR4
|
XK related 4 |
chr6_+_19837362 | 0.56 |
ENST00000378700.8
|
ID4
|
inhibitor of DNA binding 4, HLH protein |
chr20_+_23035312 | 0.56 |
ENST00000255008.5
|
SSTR4
|
somatostatin receptor 4 |
chr1_-_157138474 | 0.55 |
ENST00000326786.4
|
ETV3
|
ETS variant transcription factor 3 |
chr19_+_797443 | 0.55 |
ENST00000356948.11
ENST00000394601.8 ENST00000589575.5 ENST00000587191.3 |
PTBP1
|
polypyrimidine tract binding protein 1 |
chr10_+_45374167 | 0.55 |
ENST00000542434.5
|
ALOX5
|
arachidonate 5-lipoxygenase |
chr19_+_56538948 | 0.55 |
ENST00000301318.8
ENST00000591844.5 |
ZFP28
|
ZFP28 zinc finger protein |
chr2_-_100104530 | 0.55 |
ENST00000432037.5
ENST00000673232.1 ENST00000423966.6 ENST00000409236.6 |
AFF3
|
AF4/FMR2 family member 3 |
chr10_-_116742584 | 0.55 |
ENST00000674205.1
|
HSPA12A
|
heat shock protein family A (Hsp70) member 12A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.5 | 1.4 | GO:1903400 | L-arginine transmembrane transport(GO:1903400) |
0.5 | 0.5 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.4 | 3.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.4 | 1.7 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.4 | 1.5 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 1.1 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.3 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 1.0 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.3 | 1.0 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.3 | 2.2 | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.3 | 0.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.9 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.3 | 1.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 1.2 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 0.9 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 1.2 | GO:2000722 | regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) |
0.3 | 1.7 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.3 | 0.8 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.3 | 0.8 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.3 | 0.8 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.3 | 0.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 4.0 | GO:0032341 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) |
0.3 | 2.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 0.8 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.3 | 1.0 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.2 | 1.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 1.0 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 0.5 | GO:0071931 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) |
0.2 | 0.7 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.2 | 0.2 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
0.2 | 1.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.7 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 0.9 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.2 | 0.7 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
0.2 | 0.9 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.2 | 0.7 | GO:0036047 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
0.2 | 1.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.2 | 2.0 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.2 | 0.7 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
0.2 | 1.7 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.6 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.2 | 0.6 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.2 | 0.8 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.2 | 0.2 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.2 | 0.6 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.2 | 0.2 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.2 | 3.4 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.2 | 1.0 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.2 | 0.8 | GO:0046671 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.2 | 0.4 | GO:0003192 | mitral valve formation(GO:0003192) |
0.2 | 0.6 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.2 | 1.8 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 0.6 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.2 | 0.6 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.2 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.2 | 0.9 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 0.8 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.2 | 0.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.2 | 0.6 | GO:0071893 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.2 | 0.2 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.2 | 1.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 0.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.7 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.2 | 0.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.5 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.2 | 0.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 0.5 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.2 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.2 | 0.5 | GO:0030719 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.2 | 1.2 | GO:0050893 | sensory processing(GO:0050893) |
0.2 | 0.7 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.2 | 0.2 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.2 | 1.0 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.2 | 0.5 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.2 | 0.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.5 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.2 | 0.5 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.2 | 1.0 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 1.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.5 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.2 | 0.5 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.2 | 1.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 1.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 0.8 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.5 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.2 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.6 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 1.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 0.5 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.2 | 0.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 0.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.3 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.2 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.4 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.6 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.6 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.4 | GO:0035498 | carnosine metabolic process(GO:0035498) |
0.1 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.4 | GO:0097187 | dentinogenesis(GO:0097187) |
0.1 | 1.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 1.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 1.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 1.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.3 | GO:0044467 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
0.1 | 0.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.1 | GO:0060197 | cloacal septation(GO:0060197) |
0.1 | 1.5 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.1 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.3 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 1.0 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.4 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.1 | 0.3 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.1 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.1 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
0.1 | 1.1 | GO:0035934 | corticosterone secretion(GO:0035934) |
0.1 | 1.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.1 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.1 | 0.8 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.1 | 0.5 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.6 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 0.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.9 | GO:0072300 | regulation of metanephric glomerulus development(GO:0072298) positive regulation of metanephric glomerulus development(GO:0072300) |
0.1 | 0.5 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.1 | 0.6 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.1 | 0.2 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.5 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.5 | GO:0052031 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.1 | 0.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 2.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 1.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 1.3 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 0.4 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.1 | 0.6 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 1.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.2 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.1 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.1 | 0.1 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.1 | 0.3 | GO:1905069 | allantois development(GO:1905069) |
0.1 | 0.5 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 0.3 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.1 | 0.2 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.1 | 0.1 | GO:0060458 | right lung development(GO:0060458) |
0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.4 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.1 | 0.3 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.3 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 0.2 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
0.1 | 0.3 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 1.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 1.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 1.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.4 | GO:0034699 | response to luteinizing hormone(GO:0034699) |
0.1 | 0.1 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.1 | 0.3 | GO:0072021 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
0.1 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.4 | GO:1904021 | negative regulation of G-protein coupled receptor internalization(GO:1904021) |
0.1 | 0.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.2 | GO:0043385 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.1 | 0.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 0.4 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.1 | 0.5 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.1 | 0.5 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 0.3 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 2.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 1.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.1 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.1 | 0.3 | GO:2000753 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
0.1 | 1.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 1.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.8 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.1 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 1.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.3 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.3 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.3 | GO:1904398 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
0.1 | 0.4 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.1 | 1.0 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0070662 | mast cell proliferation(GO:0070662) |
0.1 | 0.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.4 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.1 | 0.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.4 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.1 | 0.4 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.3 | GO:0097274 | urea homeostasis(GO:0097274) |
0.1 | 0.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 1.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.7 | GO:0061709 | reticulophagy(GO:0061709) |
0.1 | 1.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.1 | GO:2001076 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.1 | 0.4 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.1 | 0.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.6 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.1 | 0.3 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.1 | 0.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.1 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.1 | 0.6 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.1 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.3 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.1 | 0.3 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.1 | 0.6 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.1 | 0.2 | GO:0051939 | gamma-aminobutyric acid import(GO:0051939) |
0.1 | 0.9 | GO:0009304 | tRNA transcription(GO:0009304) |
0.1 | 0.7 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 0.2 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.1 | 0.5 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 1.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
0.1 | 0.2 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
0.1 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 3.0 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 1.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 1.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:1903949 | positive regulation of actin filament-based movement(GO:1903116) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.1 | 1.3 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.2 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.1 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.3 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.1 | 2.3 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.5 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.1 | 0.6 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 0.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.8 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.6 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.2 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 1.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.1 | 0.2 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.1 | GO:0071464 | positive regulation of anagen(GO:0051885) cellular response to hydrostatic pressure(GO:0071464) |
0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 1.5 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
0.1 | 0.7 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 0.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.6 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.6 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.3 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.5 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 0.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 0.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.3 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
0.1 | 0.4 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.8 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 0.6 | GO:1903276 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.1 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.3 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
0.1 | 0.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.1 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
0.1 | 0.2 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.1 | 0.1 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.1 | 1.4 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.7 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
0.1 | 0.5 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.2 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
0.1 | 0.3 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.1 | 0.3 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.3 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 0.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.5 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.2 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.1 | 0.6 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.1 | 0.7 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 1.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.3 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
0.1 | 0.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.3 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 1.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 1.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.3 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 0.1 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
0.1 | 0.6 | GO:2000620 | innate vocalization behavior(GO:0098582) positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.1 | 0.3 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 0.2 | GO:1902846 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.1 | 0.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.1 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.1 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.1 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
0.1 | 0.2 | GO:0019056 | modulation by virus of host transcription(GO:0019056) regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.2 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.2 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.3 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.7 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.5 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 0.5 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 0.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 3.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.5 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.1 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.1 | 0.1 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.1 | 1.8 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.3 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.1 | 0.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
0.1 | 2.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.2 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.1 | 0.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.1 | 0.2 | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.1 | 0.3 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.1 | 0.5 | GO:0031444 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 1.4 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.1 | 0.2 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 0.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.6 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.1 | 0.2 | GO:0014813 | skeletal muscle satellite cell commitment(GO:0014813) |
0.1 | 0.1 | GO:0051586 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.9 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 1.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.1 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.1 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.2 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
0.1 | 1.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.1 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.2 | GO:0048749 | compound eye development(GO:0048749) |
0.1 | 0.1 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.1 | 0.2 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.1 | 0.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.1 | 0.4 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.1 | 0.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.2 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.4 | GO:0010269 | response to selenium ion(GO:0010269) |
0.1 | 0.1 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.2 | GO:0018032 | protein amidation(GO:0018032) |
0.1 | 0.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 0.1 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
0.1 | 0.3 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 0.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 2.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.4 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.2 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.3 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.1 | 1.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.1 | 0.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.1 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.0 | 0.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.4 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.0 | 0.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.2 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
0.0 | 0.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.0 | 0.1 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.0 | 2.2 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.1 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.0 | 0.0 | GO:1903384 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
0.0 | 0.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.0 | 0.4 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.9 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.0 | 1.4 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 0.0 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.0 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.4 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.0 | 0.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.0 | 0.1 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.0 | 0.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.0 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.0 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.0 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.2 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.0 | 0.2 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 0.1 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.6 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.8 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.6 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.0 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.2 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.0 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.0 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.0 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.1 | GO:1903347 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.0 | 0.0 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.0 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 0.4 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.9 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.1 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.0 | 0.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.0 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.4 | GO:0042424 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.3 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.6 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.0 | 0.1 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.0 | 0.4 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.1 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.0 | 0.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.6 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.0 | 0.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.0 | 0.4 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.2 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.0 | 0.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.0 | 0.1 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.0 | 0.1 | GO:0051938 | L-glutamate import(GO:0051938) |
0.0 | 0.0 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.3 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.0 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.0 | 0.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.1 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) |
0.0 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.0 | 1.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.8 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.0 | 0.4 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.0 | 0.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.9 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.0 | 0.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 0.2 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.0 | 0.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.5 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.7 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:1902617 | response to fluoride(GO:1902617) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.2 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.0 | 0.1 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.5 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.9 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.0 | 0.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 0.4 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.0 | 0.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.0 | 0.1 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.0 | 0.2 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.0 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.0 | 0.2 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.0 | 0.1 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.0 | 0.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.7 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.7 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.1 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.1 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
0.0 | 0.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.1 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
0.0 | 0.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.0 | 0.0 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.0 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.0 | 0.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.0 | 0.8 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.0 | 0.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.0 | 0.3 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.0 | 1.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.1 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.2 | GO:2000690 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.0 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) isoleucine catabolic process(GO:0006550) |
0.0 | 0.0 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.0 | 0.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.0 | 0.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.0 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.3 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0072176 | nephric duct development(GO:0072176) |
0.0 | 0.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 0.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.0 | 0.1 | GO:1902594 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
0.0 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.0 | 0.6 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.8 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 1.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.2 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.0 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.1 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.0 | 0.1 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.0 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.0 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.0 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.0 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.1 | GO:0035822 | gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.7 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.4 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.1 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
0.0 | 0.9 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.3 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.0 | 0.2 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.0 | 0.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.0 | GO:0099612 | protein localization to axon(GO:0099612) |
0.0 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.1 | GO:0009386 | translational attenuation(GO:0009386) |
0.0 | 0.1 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.0 | 0.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.0 | 0.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.9 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.0 | 1.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.1 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.0 | 0.1 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
0.0 | 0.1 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.6 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.0 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 0.8 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.1 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.0 | 0.2 | GO:0031437 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.0 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.0 | 0.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.0 | 0.1 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.0 | 0.1 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.0 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
0.0 | 0.0 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.1 | GO:0016116 | tetraterpenoid metabolic process(GO:0016108) carotenoid metabolic process(GO:0016116) carotene catabolic process(GO:0016121) xanthophyll metabolic process(GO:0016122) terpene catabolic process(GO:0046247) |
0.0 | 0.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 1.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 0.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.0 | 0.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:1903909 | regulation of receptor clustering(GO:1903909) |
0.0 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.0 | 0.5 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.6 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.4 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 1.5 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.2 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.6 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 1.3 | GO:0060078 | regulation of postsynaptic membrane potential(GO:0060078) |
0.0 | 0.1 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.0 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.0 | 0.7 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.1 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
0.0 | 0.1 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.0 | 0.2 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.3 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 0.0 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.0 | 0.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.0 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.9 | GO:0050881 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.0 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 1.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0006147 | guanine catabolic process(GO:0006147) |
0.0 | 1.1 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.0 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.0 | 0.0 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.0 | 0.1 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.0 | 0.0 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.0 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.0 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 0.2 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.0 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.3 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.0 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.1 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.1 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.0 | 0.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 2.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.0 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.0 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.0 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.0 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.5 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.2 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.0 | 0.0 | GO:0009631 | cold acclimation(GO:0009631) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.1 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.0 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.0 | 0.1 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.0 | 2.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:0034414 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
0.0 | 0.2 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.0 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.3 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.1 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
0.0 | 0.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) |
0.0 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.0 | 0.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.0 | 0.1 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.0 | 0.1 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.0 | 0.2 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.0 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.0 | 0.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.0 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
0.0 | 0.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.0 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.0 | 0.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.0 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.0 | 0.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.4 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.0 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:1903537 | meiotic spindle elongation(GO:0051232) meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.1 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.0 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.0 | 0.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.0 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.0 | 0.0 | GO:0044691 | tooth eruption(GO:0044691) |
0.0 | 0.3 | GO:0014044 | Schwann cell development(GO:0014044) |
0.0 | 0.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.0 | GO:0046066 | dGDP metabolic process(GO:0046066) |
0.0 | 0.4 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.0 | 0.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.0 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.3 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.0 | 0.0 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.0 | 0.3 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.1 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.0 | 0.0 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.0 | 0.2 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.0 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.0 | 0.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.0 | 0.1 | GO:1904588 | thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) response to thyrotropin-releasing hormone(GO:1905225) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
0.0 | 0.0 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.0 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.0 | 2.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 1.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.0 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.0 | 0.0 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 0.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.4 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.0 | 0.1 | GO:0051958 | methotrexate transport(GO:0051958) |
0.0 | 0.0 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.0 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.0 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.0 | 0.3 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.0 | 0.0 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.0 | 0.0 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.0 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.0 | 0.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.0 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.3 | 1.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 1.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.2 | 0.7 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.2 | 1.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 1.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 0.9 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.2 | 0.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.2 | 0.7 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.2 | 2.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.9 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.2 | 1.0 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.2 | 4.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.5 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 0.7 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.2 | 0.9 | GO:0045160 | myosin I complex(GO:0045160) |
0.2 | 0.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 1.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 2.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.4 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 0.4 | GO:0097545 | axonemal outer doublet(GO:0097545) |
0.1 | 1.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.4 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 1.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 1.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.5 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.1 | 0.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.5 | GO:0097196 | Shu complex(GO:0097196) |
0.1 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 1.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 1.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 2.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.5 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.1 | 2.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.6 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 2.2 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 0.5 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.1 | 8.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.5 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.3 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 1.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 1.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:0005592 | collagen type XI trimer(GO:0005592) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.2 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.1 | 0.8 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.1 | 0.4 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 1.0 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 5.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.1 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.1 | 0.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.3 | GO:1990742 | microvesicle(GO:1990742) |
0.1 | 0.2 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.1 | 0.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.1 | 0.3 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.2 | GO:0055028 | cortical microtubule(GO:0055028) |
0.1 | 0.8 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 2.6 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.3 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.1 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.1 | 0.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 3.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.1 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 1.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.2 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 0.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 1.0 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.8 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 0.9 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 6.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 2.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.0 | 1.6 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.3 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.0 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:1990879 | CST complex(GO:1990879) |
0.0 | 0.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.0 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.5 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 1.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 3.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 1.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
0.0 | 0.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.0 | 2.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 2.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 1.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 4.9 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 1.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 10.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:1990038 | glial cytoplasmic inclusion(GO:0097409) classical Lewy body(GO:0097414) Lewy neurite(GO:0097462) Lewy body corona(GO:1990038) |
0.0 | 0.1 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 1.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.0 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.2 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 5.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.0 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:1990031 | pinceau fiber(GO:1990031) |
0.0 | 1.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.0 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.6 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.3 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.0 | GO:0065010 | symbiont-containing vacuole(GO:0020003) extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.0 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 1.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 4.5 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.6 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 1.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.0 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.0 | 1.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.5 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 1.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
0.6 | 2.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 2.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 1.4 | GO:0005292 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
0.4 | 1.3 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.4 | 1.1 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.4 | 1.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.4 | 1.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.5 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.3 | 2.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 1.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 1.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 0.8 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
0.3 | 0.8 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.3 | 0.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 1.0 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 0.7 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.2 | 1.4 | GO:0039552 | RIG-I binding(GO:0039552) |
0.2 | 1.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.7 | GO:0032093 | SAM domain binding(GO:0032093) |
0.2 | 0.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 0.9 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 0.7 | GO:0036055 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
0.2 | 0.9 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.2 | 0.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.2 | 1.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.2 | 0.6 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.6 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
0.2 | 0.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.6 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
0.2 | 0.8 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.2 | 0.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 1.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.7 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.2 | 0.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.5 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 1.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 0.5 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.2 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.5 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.2 | 2.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 0.6 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
0.2 | 0.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.2 | 0.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 2.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.7 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 2.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.4 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 1.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.5 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
0.1 | 0.9 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.4 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.1 | 1.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.8 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 0.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.1 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 3.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.6 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.1 | 1.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.4 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.1 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.5 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.1 | 0.6 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 0.5 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.1 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.2 | GO:0046979 | TAP2 binding(GO:0046979) |
0.1 | 0.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.3 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
0.1 | 0.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.1 | 0.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.3 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.1 | 1.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.3 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 1.1 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 1.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 0.3 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.1 | 1.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 0.4 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
0.1 | 0.1 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.1 | 2.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 1.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 1.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.2 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 1.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 0.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 1.7 | GO:0043295 | glutathione binding(GO:0043295) |
0.1 | 3.9 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.4 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.1 | 1.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.1 | GO:0004955 | prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
0.1 | 2.4 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 1.1 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 0.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.4 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 1.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.6 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.1 | 0.4 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 1.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 1.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 1.6 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 2.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.5 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.1 | 0.5 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 0.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 1.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 1.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
0.1 | 0.9 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 1.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.4 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.3 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 2.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 1.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.2 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.1 | 0.2 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 3.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.3 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
0.1 | 0.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 1.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.5 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.3 | GO:0018271 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.1 | 0.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 0.3 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.1 | 0.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 1.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.6 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 1.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.2 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.1 | 0.2 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.2 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.1 | 1.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.2 | GO:0017129 | triglyceride binding(GO:0017129) |
0.1 | 0.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.1 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) |
0.1 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.1 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.1 | 1.5 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.1 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.2 | GO:0016497 | substance K receptor activity(GO:0016497) |
0.1 | 0.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.2 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 0.2 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.1 | 0.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 2.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 1.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.2 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.1 | 0.5 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.1 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.1 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.1 | 0.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 1.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.1 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.0 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.9 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 1.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.0 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.2 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.0 | 1.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 1.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.0 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.3 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.0 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 4.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0047708 | biotinidase activity(GO:0047708) |
0.0 | 1.4 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.0 | 0.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
0.0 | 0.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 3.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.0 | 0.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.2 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.0 | 0.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.0 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.0 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 1.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.2 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.1 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.0 | 0.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.0 | 0.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.3 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 2.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.2 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 1.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.8 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 1.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.9 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
0.0 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.0 | 0.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) beta-adrenergic receptor kinase activity(GO:0047696) |
0.0 | 0.2 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 1.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 1.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.0 | 0.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.3 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 1.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.4 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.0 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.2 | GO:1902444 | riboflavin binding(GO:1902444) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.0 | 0.5 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.4 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.0 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.0 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 1.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.1 | GO:0004040 | amidase activity(GO:0004040) |
0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.0 | 0.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0070404 | NADH binding(GO:0070404) |
0.0 | 4.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.0 | 0.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 2.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:1901474 | azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0008892 | guanine deaminase activity(GO:0008892) |
0.0 | 0.1 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.0 | 0.1 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.0 | 0.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.1 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 1.5 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 1.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0036219 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
0.0 | 2.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.1 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.0 | 0.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0035276 | ethanol binding(GO:0035276) |
0.0 | 0.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.0 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 0.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.0 | 0.4 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.1 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.0 | 1.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 1.5 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 4.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.0 | 0.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 3.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.0 | GO:0015489 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
0.0 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) inhibitory MHC class I receptor activity(GO:0032396) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.0 | 0.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.5 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.0 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.0 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.4 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.0 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.1 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.5 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 14.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 2.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 2.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.9 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 1.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 3.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 1.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 1.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 8.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 2.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 8.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 3.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 5.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 5.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 2.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 2.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 3.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 3.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.5 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 2.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 2.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 1.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 3.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.3 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 1.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 2.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 2.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 1.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 2.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 2.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 1.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 2.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 4.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 5.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.1 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.0 | 0.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 1.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.0 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.0 | 0.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.0 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |